Advertisement
Advertisement

CVS

CVS logo

CVS HEALTH CORPORATION

95.93
USD
Sponsored
+1.11
+1.17%
Jun 05, 16:00 UTC -4
Closed
exchange

After-Market

95.90

-0.03
-0.03%

CVS Earnings Reports

Positive Surprise Ratio

CVS beat 39 of 41 last estimates.

95%

Next Report

Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$101.07B
/
$1.84
Implied change from Q1 26 (Revenue/ EPS)
+0.64%
/
-28.40%
Implied change from Q2 25 (Revenue/ EPS)
+2.18%
/
+1.66%

CVS HEALTH CORPORATION earnings per share and revenue

On May 06, 2026, CVS reported earnings of 2.57 USD per share (EPS) for Q1 26, beating the estimate of 2.21 USD, resulting in a 15.80% surprise. Revenue reached 100.43 billion, compared to an expected 96.05 billion, with a 4.56% difference. The market reacted with a +7.65% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 20 analysts forecast an EPS of 1.84 USD, with revenue projected to reach 101.07 billion USD, implying an decrease of -28.40% EPS, and increase of 0.64% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Icon Plc
Report Date
May 27, 2026 For Q4 25
Estimate
$3.18
Actual
$2.52
Surprise
-20.85%
logo
HealthEquity, Inc
Report Date
May 28, 2026 For Q1 27
Estimate
$1.12
Actual
$1.24
Surprise
+10.10%
FAQ
For Q1 2026, CVS HEALTH CORPORATION reported EPS of $2.57, beating estimates by 15.8%, and revenue of $100.43B, 4.56% above expectations.
The stock price moved up 7.65%, changed from $80.69 before the earnings release to $86.86 the day after.
The next earning report is scheduled for Jul 29, 2026.
Based on 20 analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.84 and revenue of $101.07B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement